Crack prevention of implanted prostheses

• US 4,851,009 A
• Filed: 06/15/1988
• Issued: 07/25/1989
• Est. Priority Date: 12/16/1985
• Status: Expired due to Term

• Current Assignee: Lifeshield Sciences LLC (Acacia Research Corporation)
• Original Assignee: Corvita Corporation (Boston Scientific Corporation)
• Inventors: Pinchuk, Leonard
• Primary Examiner(s): Apley, Richard J.
• Assistant Examiner(s): PREBILIC, PAUL B
• Application Number:
  US07/210,145
• Time in Patent Office: 405 Days
• Field of Search: 128/419 P, 128/DIG. 21, 128/335.5, 623/1, 623/11, 623/66, 623/6, 427/2
• US Class Current: 623/66.1
• CPC Class Codes: A61L 27/34 Macromolecular materials
• CPC Class Codes: A61L 27/50 Materials characterised by their function or physical properties , e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
• CPC Class Codes: C08L 83/10 Block- or graft-copolymers containing polysiloxane sequences obtained by polymerising a compound having a carbon-to-carbon double bond on to a polysiloxane C08L51/08, C08L53/00
• CPC Class Codes: Y10S 623/92 Method or apparatus for preparing or treating prosthetic

Abstract

Implantable devices having a biocompatible polymeric surface which is elastomeric and susceptible to cracking under in vivo conditions are provided which have been subjected to treatment with a crack preventative composition that includes an elastomeric silicone such as poly(dimethyl siloxane). This treatment substantially prevents cracking of the implantable device after it is implanted.

Claims

1. A method for forming an implantable device for medical use, which device is treated to substantially prevent in vivo cracking thereof, the method comprising:

providing a non-woven shaped substrate of an implantable medical device having a biocompatible polymeric surface that is elastomeric and susceptible to cracking when subjected to implantation under in vivo conditions for substantial time periods, said in vivo conditions including those that promote crack-forming degradation of said biocompatible polymeric surface, wherein said biocompatible polymeric surface is a polyurethane;

applying a crack preventative composition to said elastomeric biocompatible polymeric surface, said crack preventative composition including a silicone material being a siloxane including ##STR5## groups and, when polymerized, being elastomeric and having a predetermined surface tension, said applying step including efecting adsorption of the silicone material onto the biocompatible polymeric surface and bonding between said elastomeric silicone material and said elastomeric biocompatible polymeric surface so as to effect grafting of said polymerized elastomeric silicone material onto said elastomeric biocompatible polymeric surface; and

said providing step includes selecting said elastomeric biocompatible polymeric surface to have a surface tension that is greater than the predetermined surface tension of said silicone material.

2. The method according to claim 1, wherein said silicone rubber material of the crack preventative composition is a siloxane condensation reaction product of reactants including:

(a) a silicone moiety of the formula;

##STR6## wherein n has an average value of greater than 100; and

(b) an acetoxy silane crosslinker, ##STR7## whereby the reaction product is a poly(dimethyl siloxane).

3. The treatment method according to claim 1, wherein said crack preventative composition includes a solvent that does not detreimentally affect said biocompatible polymeric surface.

4. The treatment method according to claim 1, wherein said applying step includes imparting lubricating properties to the biocompatible polymeric surface.

5. The method according to claim 1, wherein said silicone rubber material of the crack preventative composition is a siloxane which, prior to curing, has the formula:

##STR8## wherein each R group is an organic moiety selected from the group consisting of one or more ester moieties, acetoxy moieties, acrylic moieties and alcohol moieties, wherein each R₃ and R₄ group is an organic group selected from the group consisting of aliphatic groups and substituted aliphatic groups having from 1 to about 12 carbon atoms, and aromatic groups and substituted aromatic groups having from 6 to about 20 carbon atoms, and wherein each R₁ group and R₂ group is an organic component selected from the group consisting of R, R₃ and R₄.

6. The method according to claim 1, wherein said silicone material of the crack preventative composition is poly(dimethyl siloxane).

7. A method for forming an implantable device for medical use, which device is treated to substantially prevent in vivo cracking thereof, the method comprising:

providing a non-woven shaped substrate of an implantable medical device having a biocompatible polymeric surface that is elastomeric and susceptible to cracking when subjected to implantation under in vivo conditions for substantial time periods, said in vivo conditions including those that promote crack-forming degradation of said biocompatible polymeric surface, wherein said shaped substrate includes one or more extruded fibers that are shaped by winding over a mandrel;

applying a crack preventative composition to said elastomeric biocompatible polymeric surface, said crack preventative composition including a silicone material being a siloxane including ##STR9## groups and, when polymerized, being elastomeric and having a predetermined surface tension, said applying step including effecting adsorption of the silicone material onto the biocompatible polymeric surface and bonding between said elastomeric silicone material and said elastomeric biocompatible polymeric surface so as to effect grafting of said polymerized elastomeric silicone material onto said elastomeric biocompatible polymeric surface; and

said providing step includes selecting said elastomeric biocompatible polymeric surface to have a surface tension that is greater than the predetermined surface tension of said silicone material.

8. A method for forming an implantable device for medical use, which device is treated to substantially prevent in vivo cracking thereof, the method comprising:

providing a non-woven shaped substrate of an implantable medical device having a biocompatible polymeric surface that is elastomeric and susceptible to cracking when subjected to implantation under in vivo conditions for substantial time periods, said in vivo conditions including those that promote crack-forming degradation of said biocompatible polymeric surface, wherein said shaped substrate includes one or more strands of said biocompatible polymer;

applying a crack preventative composition to said elastomeric biocompatible polymeric surface, said crack preventative composition including a silicone material being a siloxane including ##STR10## groups and, when polymerized, being elastomeric and having a predetermined surface tension, said applying step including effecting adsorption of the silicone material onto the biocompatible polymeric surface and bonding between said elastomeric silicone material and said elastomeric biocompatible polymeric surface so as to effect grafting of said polymerized elastomeric silicone material onto said elastomeric biocompatible polymeric surface; and

said providing step includes selecting said elastomeric biocompatible polymeric surface to have a surface tension that is greater than the predetermined surface tension of said silicone material.

9. An implantable device for medical use under in vivo conditions, comprising:

a shaped substrate of an implantable medical device having a biocompatible polymeric surface that is elastomeric and susceptible to degradation cracking when subjected to implantation under in vivo conditions for substantial time periods;

a crack preventative adsorbed to and grafted onto said substrate so that there is bonding between said elastomeric substrate and said crack preventative, said crack preventative being an elastomeric silicone material having a predetermined surface tension, said crack preventative being a siloxane including recurring ##STR11## groups;

said biocompatible polymeric surface has a surface tension greater than the predetermined surface tension of the crack preventative; and

said elastomeric biocompatible polymeric surface is a polyurethane.

10. The implantable device according to claim 9, wherein said crack preventative is a siloxane which, prior to curing, has the formula:

##STR12## wherein each R group is an organic moiety selected from the group consisting of one or more ester moieties, acetoxy moieties, acrylic moieties and alcohol moieties, wherein each R₃ and R₄ group is an organic group selected from the group consisting of aliphatic groups and substituted aliphatic groups having from 1 to about 12 carbon atoms, and aromatic groups and substituted aromatic groups having from 6 to about 20 carbon atoms, and wherein each R₁ group and R₂ group is an organic component selected from the group consisting of R, R₃ and R₄.

11. The implantable device according to claim 9, wherein said silicone material of the crack preventative composition is poly(dimethyl siloxane).

12. The implantable device according to claim 9, wherein said shaped substrate is a pacemaker lead insulator having a generally smooth surface of said elastomeric biocompatible polymeric material having said crack preventative bonded thereto.

13. An implantable device for medical use under in vivo conditions, comprising:

a shaped substrate of an implantable medical device having a biocompatible polymeric surface that is elastomeric and susceptible to degradation cracking when subjected to implantation under in vivo conditions for substantial time periods, wherein said shaped substrate includes one or more strands of said biocompatible polymer;

a crack preventative adsorbed to and grafted onto said substrate so that there is bonding between said elastomeric substrate and said crack preventative, said crack preventative being an elastomeric silicone material having a predetermined surface tension, said crack preventative being a siloxane including recurring ##STR13## groups; and

said biocompatible polymeric surface has a surface tension greater than the predetermined surface tension of the crack preventative.

14. An implantable device for medical use under in vivo conditions, comprising:

a shaped substrate of an implantable medical device having a biocompatible polymeric surface that is elastomeric and susceptible to degradation cracking when subjected to implantation under in vivo conditions for substantial time periods, wherein said shaped substrate includes one or more extruded fibers that are shaped by winding over a mandrel;

a crack preventative adsorbed to and grafted onto said substrate so that there is bonding between said elastomeric substrate and said crack preventative, said crack preventative being an elastomeric silicone material having a predetermined surface tension, said crack preventative being a siloxane including recurring ##STR14## groups; and

said biocompatible polymeric surface has a surface tension greater than the predetermined surface tension of the crack preventative.

15. An implantable device for medical use under in vivo conditions, comprising:

a shaped substrate of an implantable medical device having a biocompatible polymeric surface that is elastomeric and susceptible to degradation cracking when subjected to implantation under in vivo conditions for substantial time periods;

a crack preventative adsorbed to and grafted onto said substrate so that there is bonding between said elastomeric substrate and said crack preventative, said crack preventative being an elastomeric silicone material having a predetermined surface tension, said crack preventative being a siloxane including recurring ##STR15## groups;

said biocompatible polymeric surface has a surface tension greater than the predetermined surface tension of the crack preventative; and

said shaped substrate is a graft including wound strands of extruded fiber that overlie and intersect one another, and said extruded fiber is said elastomeric biocompatible polymeric surface having said crack preventative bonded thereto.

16. An implantable device for medical use under in vivo conditions, comprising:

a shaped substrate of an implantable medical device having a biocompatible polymeric surface that is elastomeric and susceptible to degradation cracking when subjected to implantation under in vivo conditions for substantial time periods;

a crack preventative adsorbed to and grafted onto said substrate so that there is bonding between said elastomeric substrate and said crack preventative, said crack preventative being an elastomeric silicone material having a predetermined surface tension, said crack preventative being a siloxane including recurring ##STR16## groups;

said biocompatible polymeric surface has a surface tension greater than the predetermined surface tension of the crack preventative; and

said shaped substrate is a suture including an extruded fiber that is composed of said elastomeric biocompatible polymeric surface having said crack preventative bonded thereto.

17. An implantable device for medical use under in vivo conditions, comprising:

a shaped substrate of an implantable medical device having a biocompatible polymeric surface that is elastomeric and susceptible to degradation cracking when subjected to implantation under in vivo conditions for substantial time periods;

a crack preventative adsorbed to and grafted onto said substrate so that there is bonding between said elastomeric substrate and said crack preventative, said crack preventative being an elastomeric silicone material having a predetermined surface tension, said crack preventative being a siloxane including recurring ##STR17## groups;

said biocompatible polymeric surface has a surface tension greater than the predetermined surface tension of the crack preventative; and

said elastomeric biocompatible polymeric surface is a polyurethane, and said crack preventative bonded thereto is acetoxy terminated poly(dimethyl siloxane).

18. A method for forming an implantable device for medical use, which device is treated to substantially prevent in vivo cracking thereof, the method comprising:

providing a non-woven shaped substrate of an implantable medical device having a biocompatible polymeric surface that is elastomeric and susceptible to cracking when subjected to implantation under in vivo conditions for substantial time periods, said in vivo conditions including those that promote crack-forming degradation of said biocompatible polymeric surface, wherein said elastomeric biocompatible polymeric surface is a polyurethane, and wherein said crack preventative bonded thereto is acetoxy terminated poly(dimethyl siloxane);

applying a crack preventative composition to said elastomeric biocompatible polymeric surface, said crack preventative composition including a silicone material being a siloxane including ##STR18## groups and, when polymerized, being elastomeric and having a predetermined surface tension, said applying step including effecting adsorption of the silicone material onto the biocompatible polymeric surface and bonding between said elastomeric silicone material and said elastomeric biocompatible polymeric surface so as to effect grafting of said polymerized elastomeric silicone material onto said elastomeric biocompatible polymeric surface; and

said providing step includes selecting said elastomeric biocompatible polymeric surface to have a surface tension that is greater than the predetermined surface tension of said silicone material.